Bohui Innovation: Jointly Controlled Subsidiary Obtains Drug Clinical Trial Approval Letter

Bohui Innovation Announcement: Bohui Biopharmaceutical Co., Ltd., a subsidiary held by Bohui, jointly applied for the freeze-dried human rabies vaccine with Beijing Baihui Biotechnology Co., Ltd., and obtained the "Notice of Approval for Drug Clinical Trial" issued by the National Medical Products Administration, approving the conduct of clinical trials.